Previous 10 |
Almost two-thirds of all IPOs in the 3Q were healthcare or tech, along with 7 of the top 10 best-performing IPOs. The healthcare sector had 14 offerings raise $4.0 billion; deal flow was driven by biotechs (7) and diagnostics companies (3), while two dental products makers represented about ha...
Pfenex (NYSEMKT: PFNX ) +13% as FDA OKs Pfenex Forteo biosimilar. More news on: Pfenex Inc., Mereo BioPharma Group plc, Livongo Health, Inc., Stocks on the move, Read more ...
YOQNEAM, Israel , Oct. 3, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced that it has completed the establishment of two new subsidiaries in the Asia Pacific region - InMode India, located in ...
Gainers: LATAM Airlines Group (NYSE: LTM ) +30% . Just Energy Group (NYSE: JE ) +26% . Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) +20% . Tiziana Life Sciences PLC (NASDAQ: TLSA ) +20% . Contango Oil & Gas Company (NYSEMKT: MCF ) +14% . Ra Medical Systems, Inc. (NYSE: R...
LAKE FOREST, Calif. , Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical professionals at its Inaugural North American User Meeting, titled the "Insider Summit," in ...
After industry watchers at Wall Street research firms unveiled bullish ratings, shares of InMode (NASDAQ: INMD) jumped 12.9% on Wednesday. The medical device company markets equipment to harness RF frequencies to perform medical aesthetic and women's health procedures, including body c...
Correvio Pharma (NASDAQ: CORV ) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald. More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...